Water Loss and Atopic Dermatitis

Trial Objective

Water Loss and Atopic DermatitisResearchers are studying how much water is lost from the skin of patients with Atopic Dermatitis (eczema) before and after using the medication Dupilumab. Patients’ skin will be tested through a noninvasive process called skin taping to study protein levels in the skin. 

Enrollment

Active Clinical Trials Currently Recruiting

Who Can Participate

Adolescents 12-17, Adults 18-65-years-old

Age: 12-65    Gender: Any Gender


Estimated Time Commitment

13 visits over 24 weeks



Payment & Reimbursement  

Payment: Provided

Travel Reimbursement: Not Available

Trial Contact

For more information, contact:

Marco Ramirez-Gama
303.398.1409

Request More Information

Trial Location

National Jewish Main Campus, Denver, CO

Trial Sponsors

Sanofi-Aventis 


Request More Information

Complete this form to learn more about this study and see if you qualify.


*
*
*
*